Pitfalls and Prevention Strategies for Liquid Chromatography-Tandem Mass Spectrometry in the Selected Reaction– Monitoring Mode for Drug Analysis
- 1 September 2008
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 54 (9) , 1519-1527
Abstract
Background: We observed cases of false-positive results with the use of liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS). Different LC-MS/MS techniques that use the selected reaction-monitoring mode, routinely employed for the analysis and quantification of drugs and toxic compounds in biological matrices, were involved in the false-positive and potentially false-positive results obtained. We sought to analyze the causes of and solutions to this problem.Methods: We used a previously reported LC-MS/MS general unknown screening method, as well as manual spectral investigation in 1 case, to perform verification and identification of interfering compounds.Results: We observed that false-positive results involved: a metabolite of zolpidem that might have been mistaken for lysergic acid diethylamide, benzoylecgonine mistaken for atropine, and clomipramine and 3 phenothiazines that share several common ion transitions.Conclusions: To prevent problems such as those we experienced, we recommend the use of stable-isotope internal standards when possible, relative retention times, 2 transitions or more per compound when possible, and acceptable relative abundance ratios between transitions, with an experience-based tolerance of ±15% for transitions with a relative abundance >10% and with an extension to ±25% for transitions <10% when the concentration is at the limit of quantification. A powerful general unknown screening procedure can help to confirm suspected interferences. Our results indicate that the specificity of screening procedures is questionable for LC-MS/MS analyses performed in the selected reaction-monitoring mode and involving a large number of compounds with only 1 transition per compound.Keywords
This publication has 29 references indexed in Scilit:
- Quantitative determination of forty-eight antidepressants and antipsychotics in human serum by HPLC tandem mass spectrometry: A multi-level, single-sample approachJournal of Chromatography B, 2006
- Quantification by HPLC-MS/MS of Atropine in Human Serum and Clinical Presentation of Six Mild-to-Moderate Intoxicated Atropine-Adulterated-Cocaine UsersTherapeutic Drug Monitoring, 2006
- A Fully Automated Turbulent-Flow Liquid Chromatography-Tandem Mass Spectrometry Technique for Monitoring Antidepressants in Human SerumTherapeutic Drug Monitoring, 2006
- Identification of chemical compoundsTrAC Trends in Analytical Chemistry, 2005
- Development of a multi‐target screening analysis for 301 drugs using a QTrap liquid chromatography/tandem mass spectrometry system and automated library searchingRapid Communications in Mass Spectrometry, 2005
- Confirmatory analysis for drugs of abuse in plasma and urine by high-performance liquid chromatography?tandem mass spectrometry with respect to criteria for compound identificationJournal of Chromatography B, 2004
- The characterisation of selected drugs with amine-containing side chains using electrospray ionisation and ion trap mass spectrometry and their determination by HPLC–ESI-MSJournal of Pharmaceutical and Biomedical Analysis, 2004
- Criteria for the identification of compounds by liquid chromatography–mass spectrometry and liquid chromatography–multiple mass spectrometry in forensic toxicology and doping analysisAnalytica Chimica Acta, 2003
- Simultaneous screening for 238 drugs in blood by liquid chromatography–ionspray tandem mass spectrometry with multiple-reaction monitoringJournal of Chromatography B, 2003
- Zolpidem metabolism in vitro: responsible cytochromes, chemical inhibitors, and in vivo correlationsBritish Journal of Clinical Pharmacology, 1999